Colin Swanton is a finance professional and ACA Chartered Accountant with extensive experience in corporate finance, FP&A, and business partnering. Colin's career includes a significant tenure at Grant Thornton from 2013 to 2021, where they contributed to M&A, valuations, and due diligence. Since 2022, Colin has been an FP&A Analyst at Zymeworks Biopharmaceuticals, focusing on budgeting and forecasting, and is currently a Manager in Finance Business Partnering at ICON plc. Colin holds multiple degrees in finance and accounting, having completed a Master's in Corporate Finance and earning the FMVA designation from the Corporate Finance Institute. Passionate about transforming financial data into strategic insights, Colin enjoys building connections and mentoring others in the finance field.
This person is not in any teams
This person is not in any offices